(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 4.98% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.
Bruker's revenue in 2026 is $3,458,500,000.On average, 17 Wall Street analysts forecast BRKR's revenue for 2026 to be $557,145,783,840, with the lowest BRKR revenue forecast at $533,703,037,744, and the highest BRKR revenue forecast at $575,108,407,472. On average, 17 Wall Street analysts forecast BRKR's revenue for 2027 to be $580,892,981,184, with the lowest BRKR revenue forecast at $549,230,051,392, and the highest BRKR revenue forecast at $609,359,172,872.
In 2028, BRKR is forecast to generate $610,272,526,616 in revenue, with the lowest revenue forecast at $574,651,730,600 and the highest revenue forecast at $652,895,701,336.